Company / Accounts Receivable
Avanos Medical, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$103.8M
FY2025
5-year range
$103.8M / $167.9M
FY2021-FY2025
Trend
-21.8%
vs FY2024
Sector context
#97 of 143
Health Care
What the data says
At $104M, Avanos Medical, Inc.'s accounts receivable ranks #97 of 143 in the Health Care sector. Accounts Receivable has declined for 3 consecutive years, from $168M in FY2022 to $104M in FY2025.
Based on SEC 10-K filings.
$104M in FY2025 with a 5-year CAGR of -0.9%.
Declined from $143M to $104M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -14.8%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
#97 of 143 in Health CareTop 68% of 143This company $103.8M Sector average $1.3B
▼
-92.2% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s accounts receivable has declined for 3 consecutive years.
- 5-year CAGR of -0.9%, indicating a declining trend.
- In FY2025, accounts receivable decreased 21.8% year-over-year.
- Ranks #97 out of 143 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $103.8M | -21.8% |
| FY2024 | $132.8M | -7.0% |
| FY2023 | $142.8M | -14.9% |
| FY2022 | $167.9M | +28.0% |
| FY2021 | $131.2M | +20.8% |
| FY2020 | $108.6M | -33.7% |
| FY2019 | $163.8M | +8.8% |
| FY2018 | $150.5M | -25.9% |
| FY2017 | $203.0M | +7.7% |
| FY2016 | $188.5M | -16.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026